New Delhi: In another milestone in India’s vaccination feat, a locally developed vaccine against the coronavirus – Covaxin – has now been recognized “around the world” as a “universal vaccine for adults and children”. “COVAXIN is now a universal vaccine for adults and children. Our goals of developing a global vaccine against COVID-19 have been …
New Delhi: The CDSCO (Central Medicines Standards Control Organization) expert committee has approved the administration of Covaxin to children between the ages of 2 and 18, according to official sources. After a meeting yesterday, the SEC sent its recommendation to the Drug Controller General of India for approval. Phase II and III trials were conducted …
CDSCO Expert Panel recommends emergency use of Covaxin for children aged 2-18 Read More »
Indian Immunological Limited (IIL) is a name that may have been heard by some outside the vaccine industry. But the vaccine manufacturer hopes to play an important role in Bharat Biotech’s ambitious plan, which will increase production of covaxin to 700 million doses annually. IIL executive officers are overdue to revive the newly built manufacturing …
IIL is ready to roll out Bharat Biotech’s Covaxin drug substance by July-August Read More »
New Delhi: The nasal vaccine, made by Hyderabad-based Bharat Biotech, could be a game-changer if it provides mucosal immunity, a senior epidemiologist at the Indian Institute of Medical Sciences (AIIMS) in Delhi has said. According to Senior Epidemiologist Dr. Sanjay Rai, this vaccine could be a great achievement for the human race if this nasal …
Bharat Biotech on May 27 signed a MoU with the Gujarat Covid Vaccine Consortium (GCVC) to contract a drug product Covaxin. The Gujarat Covid Vaccine Consortium (GCVC) contains Hester Biosciences, the Gujarat Biotechnology Research Center (GBRC), the Gujarat Government and Omnibrx Biotechnologies. According to the MoU, Bharat Biotech will provide Covaxin drug production technology. The …
Bharat Biotech joins MoU and GCVC to produce Covaxin drug product Read More »
New Delhi: The World Health Organization (WHO) will take the long-awaited decision on the submission of Hyderabad-based vaccine manufacturer Bharat Biotech requesting an Emergency Use List (EUL) for its Covid-19 vaccine Covaxin the next week. “WHO and a group of independent experts are to meet next week to conduct the risk/benefit assessment and make the …
Decision On WHO Emergency Approval For Covaxin Postponed To Next Week Read More »
